EXACT Sciences (EXAS) vs. Puma Biotechnology (PBYI) Head-To-Head Survey
EXACT Sciences and Puma Biotechnology are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and profitability. EXACT Sciences has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500.
from Biotech News
0 Comments